- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
MAPILC3A Antibody (C-term)Rabbit Monoclonal Antibody
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AJ1456b | 100ul 400 ul | 2-3 days | $ 315.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
MAPILC3A Antibody (C-term) - Product info | |
| Application | WB, IHC
|
| Primary Accession | Q9H492 |
| Reactivity | Human, Mouse, Rat |
| Clone Names | EP1983Y |
| Calculated MW | 14272 Da |
| Gene ID 84557 | |
| Other Names MAP1LC3A, Microtubule-associated proteins 1A/1B light chain 3A, Microtubule-associated protein 1 light chain 3 alpha;MAP1A/1B light chain 3 A;MAP1A/MAP1B LC3 A;MAP1 light chain 3-like protein 1;Autophagy-related protein LC3 A;Autophagy-related ubiquitin-like modifier LC3 A | |
| Target/Specificity A synthetic peptide corresponding to residues on the C-terminus of human MAPILC3A was used as an immunogen. | |
| Dilution WB~~1:10000 IHC~~1:100~250 | |
| Format 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions MAPILC3A Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
MAPILC3A Antibody (C-term) - Protein Information | |
| Name MAP1LC3A | |
| Function Involved in formation of autophagosomal vacuoles (autophagosomes) | |
| Cellular Location Cytoplasm, cytoskeleton. Endomembrane system; Lipid-anchor. Cytoplasmic vesicle, autophagosome membrane; Lipid-anchor. Cytoplasmic vesicle, autophagosome. Note=LC3-II binds to the autophagic membranes | |
| Tissue Location Most abundant in heart, brain, liver, skeletal muscle and testis but absent in thymus and peripheral blood leukocytes | |
MAPILC3A Antibody (C-term) - Related products
AM1823a: APG8a (MAP1LC3A)-S12 Antibody
AP1801a: LC3 Antibody (APG8A) (N-term)
AP1801b: LC3 Antibody (APG8A) (P45)
AP1801c: LC3 Antibody (APG8A) (I31)
AP1801d: LC3 Antibody (APG8A) (D106)
AP1801e: LC3 Antibody (APG8A) (S12)
AP1801f: LC3 Antibody (APG8A) (S3)
AP1801g: LC3 Antibody (APG8A) (T93/Y99)
AP1801h: LC3 Antibody (APG8A) (T93/Y99)
AP1801i: LC3 Antibody (Isoform B Specific)
AP1805a: Cleaved LC3A Antibody
AP3301a: Phospho-LC3C-S12 Antibody
AP3620a: Phospho-LC3A-T93 Antibody
AP3641a: Phospho-LC3A-S3 Antibody
AP3706a: Phospho-APG8a (MAP1LC3A)-Y99 Antibody
RI13150: MAP1LC3A predesign siRNA
BP1801a: LC3 Antibody (APG8a) (N-term) Blocking Peptide
BP1801b: LC3 (APG8a) Antibody (P45) Blocking Peptide
BP1801c: LC3 Antibody (APG8a) (I31) Blocking Peptide
BP1801d: LC3 Antibody (APG8a) (D106) Blocking Peptide
BP1801e: APG8a (MAP1LC3A) Antibody (S12) Blocking Peptide
BP1801f: APG8a (MAP1LC3A) Antibody (S3) Blocking Peptide
BP1801g: APG8a (MAP1LC3A) Antibody (T93/Y99) Blocking Peptide
BP1801h: APG8a (MAP1LC3A) Antibody (T93/Y99) Blocking Peptide
BP1801i: APG8a (MAP1LC3A) Antibody (Isoform b specific) Blocking Peptide
BP1805a: Cleaved-LC3 Antibody (APG8a) Blocking Peptide
BP3301a: Phospho-LC3 (APG8a) - S12 Antibody Blocking Peptide
BP3620a: Phospho-APG8a (MAP1LC3A)-pT93 Antibody Blocking Peptide
BP3641a: Phospho-APG8a (MAP1LC3A)-pS3 Antibody Blocking Peptide
BP3706a: Phospho-APG8a(MAP1LC3A)-Y99 Antibody Blocking Peptide
MAPILC3A Antibody (C-term) - Application data
-
A. Western blot analysis on HeLa cell lysate using anti-MAPILC3A RabMAb (Cat. #AJ1456b).
-
B. Immunohistochemical staining of paraffin-embedded human breast carcinoma using anti-MAPILC3A RabMAb (Cat. #AJ1456b).
MAPILC3A Antibody (C-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Microtubule-associated MAPILC3A constitute nearly half of the mass of all the microtubule associated proteins that copurify with brain microtubules. MAPILC3A is composed of a heavy chain and multiple light-chain subunits. Amino acid sequencing of a 120 kd microtubule-binding and light chain-binding fragment of the heavy chain reveals that light chain 1 binds near the heavy chain N-terminus. These data indicate that the heavy chain and light chain 1 are produced by proteolytic processing of a MAP1B polyprotein and form a complex microtubule-binding domain (1). There are three human orthologs of the rat Map1LC3, named MAP1LC3A, MAP1LC3B, and MAP1LC3C. The three isoforms of human MAP1LC3 exhibit distinct expression patterns in different human tissues and also differ in their post-translation modifications. MAP1LC3A and MAP1LC3C are produced by the proteolytic cleavage after the conserved C-terminal Gly residue; MAP1LC3B does not undergo C-terminal cleavage and exists in a single modified form (2).
REFERENCES
1. Hammarback JA, et al. Neuron 7(1):129-39, 1991.
2. He H, et al. J. Biol Chem 278(31):29278-87, 2003.